SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-08-171535
Filing Date
2008-08-08
Accepted
2008-08-08 12:54:59
Documents
5
Period of Report
2008-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 266004
2 SETTLEMENT AND RELEASE AGREEMENT dex101.htm EX-10.1 129628
3 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 5687
4 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 5718
5 SECTION 906 CEO AND CFO CERTIFICATION dex321.htm EX-32.1 5434
  Complete submission text file 0001193125-08-171535.txt   413923
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Filer) CIK: 0000730272 (see all company filings)

IRS No.: 042729386 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-14656 | Film No.: 081001480
SIC: 2836 Biological Products, (No Diagnostic Substances)